Mereo Biopharma Group Plc ADR (MREO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,992 | 69,802 | 57,421 | 68,182 | N/A |
| Marketable Securities | N/A | N/A | N/A | N/A | 129,666 |
| Receivables | N/A | N/A | N/A | N/A | 3,064 |
| Other current assets | 1,497 | 2,786 | 1,183 | 1,569 | 0 |
| TOTAL | $45,020 | $74,763 | $63,760 | $75,197 | $136,579 |
| Non-Current Assets | |||||
| PPE Net | 137 | 257 | 405 | 551 | 3,479 |
| Intangibles | 516 | 643 | 1,089 | 0 | 33,778 |
| Other Non-Current Assets | 244 | 727 | 1,245 | 1,665 | 0 |
| TOTAL | $897 | $1,627 | $2,739 | $2,216 | $37,257 |
| Total Assets | $45,917 | $76,390 | $66,499 | $77,413 | $173,836 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,333 | 2,440 | 2,346 | 3,492 | 3,436 |
| Accrued Expenses | 2,026 | 4,071 | 5,467 | 5,436 | 5,261 |
| Other current liabilities | 741 | 1,095 | 1,021 | 1,557 | 5,599 |
| TOTAL | $4,302 | $13,848 | $9,486 | $24,375 | $17,245 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 19,779 |
| Other Non-Current Liabilities | 699 | 1,573 | 6,476 | 1,636 | 15,800 |
| TOTAL | $699 | $1,573 | $6,476 | $1,636 | $35,579 |
| Total Liabilities | $5,001 | $15,421 | $15,962 | $26,011 | $52,825 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 159,616 | 159,000 | N/A | N/A | N/A |
| Common Shares | 3,135 | 3,059 | 2,775 | 2,478 | 2,413 |
| Retained earnings | -501,018 | -462,883 | -419,630 | -404,575 | -408,361 |
| Other shareholders' equity | -10,823 | -18,849 | -17,715 | -22,022 | 8,141 |
| TOTAL | $40,916 | $60,969 | $50,537 | $51,402 | $121,012 |
| Total Liabilities And Equity | $45,917 | $76,390 | $66,499 | $77,413 | $173,836 |